Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records

Author:

Sun Virginia H.12ORCID,Heemelaar Julius C.123ORCID,Hadzic Ibrahim1456ORCID,Raghu Vineet K.12ORCID,Wu Chia-Yun78,Zubiri Leyre17ORCID,Ghamari Azin12,LeBoeuf Nicole R.1910ORCID,Abu-Shawer Osama11ORCID,Kehl Kenneth L.11213ORCID,Grover Shilpa114ORCID,Singh Prabhsimranjot113,Suero-Abreu Giselle A.1215ORCID,Wu Jessica12ORCID,Falade Ayo S.16ORCID,Grealish Kelley7,Thomas Molly F.171819,Hathaway Nora7ORCID,Medoff Benjamin D.120ORCID,Gilman Hannah K.12,Villani Alexandra-Chloe12122ORCID,Ho Jor Sam12,Mooradian Meghan J.17ORCID,Sise Meghan E.123ORCID,Zlotoff Daniel A.115ORCID,Blum Steven M.172122ORCID,Dougan Michael124ORCID,Sullivan Ryan J.17,Neilan Tomas G.1215ORCID,Reynolds Kerry L.17ORCID

Affiliation:

1. Harvard Medical School, Boston, MA

2. Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, MA

3. Leiden University Medical Center, Leiden, the Netherlands

4. Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Boston, MA

5. Brigham and Women's Hospital, Boston, MA

6. Maastricht University, Maastricht, the Netherlands

7. Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA

8. Far Eastern Memorial Hospital, New Taipei City, Taiwan

9. Department of Dermatology, Brigham and Women's Hospital, Boston, MA

10. Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA

11. Department of Internal Medicine, Cleveland Clinic, Cleveland, OH

12. Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA

13. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

14. Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, MA

15. Division of Cardiology, Massachusetts General Hospital, Boston, MA

16. Internal Medicine Department, Massachusetts General Brigham Salem Hospital, Salem, MA

17. Division of Gastroenterology, Oregon Health and Science University, Portland, OR

18. Department of Medicine, Oregon Health and Science University, Portland, OR

19. Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR

20. Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA

21. Center for Immunology and Inflammatory Diseases (CIID), Massachusetts General Hospital Krantz Family Center for Cancer Research, Boston, MA

22. Broad Institute of MIT and Harvard, Cambridge, MA

23. Division of Nephrology, Massachusetts General Hospital, Boston, MA

24. Division of Gastroenterology, Massachusetts General Hospital, Boston, MA

Abstract

PURPOSE Current approaches to accurately identify immune-related adverse events (irAEs) in large retrospective studies are limited. Large language models (LLMs) offer a potential solution to this challenge, given their high performance in natural language comprehension tasks. Therefore, we investigated the use of an LLM to identify irAEs among hospitalized patients, comparing its performance with manual adjudication and International Classification of Disease (ICD) codes. METHODS Hospital admissions of patients receiving immune checkpoint inhibitor (ICI) therapy at a single institution from February 5, 2011, to September 5, 2023, were individually reviewed and adjudicated for the presence of irAEs. ICD codes and an LLM with retrieval-augmented generation were applied to detect frequent irAEs (ICI-induced colitis, hepatitis, and pneumonitis) and the most fatal irAE (ICI-myocarditis) from electronic health records. The performance between ICD codes and LLM was compared via sensitivity and specificity with an α = .05, relative to the gold standard of manual adjudication. External validation was performed using a data set of hospital admissions from June 1, 2018, to May 31, 2019, from a second institution. RESULTS Of the 7,555 admissions for patients on ICI therapy in the initial cohort, 2.0% were adjudicated to be due to ICI-colitis, 1.1% ICI-hepatitis, 0.7% ICI-pneumonitis, and 0.8% ICI-myocarditis. The LLM demonstrated higher sensitivity than ICD codes (94.7% v 68.7%), achieving significance for ICI-hepatitis ( P < .001), myocarditis ( P < .001), and pneumonitis ( P = .003) while yielding similar specificities (93.7% v 92.4%). The LLM spent an average of 9.53 seconds/chart in comparison with an estimated 15 minutes for adjudication. In the validation cohort (N = 1,270), the mean LLM sensitivity and specificity were 98.1% and 95.7%, respectively. CONCLUSION LLMs are a useful tool for the detection of irAEs, outperforming ICD codes in sensitivity and adjudication in efficiency.

Publisher

American Society of Clinical Oncology (ASCO)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3